Who we are
Immunity for Health is a leading non-profit health cluster organization dedicated to facilitating collaboration between academic, industrial and public stakeholders with relevant expertise in human and animal immunotherapeutics and vaccines. Immunity for Health stands out by combining scientific excellence, independence, and a dedicated mission to foster collaborations, advance the development of vaccines and immunotherapies, and contribute to a healthier future for everyone.
Our team, the driving force behind the seamless operation of Immunity for Health, is committed to delivering exceptional services to our members and ensuring the organization’s success. Fran Van Heuverswyn, as Project Manager, oversees daily operations and strategic execution of projects. She is also responsible for communication and event management, and the overall coordination of activities, ensuring smooth organization of impactful events and strong connections with our members.
Immunity for Health provides a unique platform that connects diverse stakeholders while offering access to expertise, cutting-edge technologies, and essential resources to advance vaccine research and development. Leveraging our extensive network, we foster cross-disciplinary collaborations, support groundbreaking research, and facilitate the translation of scientific discoveries into practical solutions. By enabling knowledge exchange and cultivating strong partnerships, we aim to enhance global health and address emerging healthcare challenges.
Fran Van Heuverswyn
Project Manager
Driving R&D Innovation Through Collaboration and Expertise
Facilitating the exchange of expertise and innovative technologies between academia and industry is a core focus of our organization. The Immunity for Health platform serves as a powerful tool to foster stronger, more impactful partnerships, ultimately contributing to improved health for all.
Immunity for Health provides essential insights and updates on research and development in immunology, vaccinology and infectious diseases.
Immunity for Health fosters collaboration across regions, sectors, and disciplines to drive innovation and address health challenges.
Collaborate with us to leverage our extensive experience and dedicated network in vaccines, immunotherapy and other related areas.
Increasing the (inter) national visibility of our reputable vaccine ecosystem.
Our Organizational Framework: Leadership, Vision, and Collaboration
Founding
Fathers
Immunity for Health was founded in January 2016 through a partnership between the five leading Flemish universities—Ghent University, University of Antwerp, University of Hasselt, University of Leuven, and Vrije Universiteit Brussel—along with the networking organization flanders.bio and the innovative biotech company BioMARIC. This collaboration unites academic excellence, industry expertise, and cutting-edge biotechnology to advance the development of vaccines and immunotherapies.
Strategic Partners
Immunity for Health is supported by a team of strategic partners who provide valuable guidance to the steering committee on advancing innovation and development in vaccines and immunotherapeutics. Their expertise helps drive progress in improving human and animal health.
Board of
Directors
The Board of Directors at Immunity for Health consists of a diverse group of highly experienced professionals from both academia and industry, ensuring a balanced representation of both sectors. This leadership team brings together expertise in key areas such as veterinary research, clinical research, immunology, immunotherapy, regulatory affairs, diagnostics, (veterinary) vaccine development, medical devices, and the broader life sciences sector.
University of Ghent,
represented by
Sven Arnouts
CHAIRMAN Immunity for Health Board of Directors
University of Antwerp,
represented by
Pierre Van Damme
VICE CHAIRMAN Immunity for Health Board of Directors
University of Hasselt,
represented by
Niels Hellings
Flanders.bio,
represented by
Katrien Lorré
University of Leuven,
represented by
Kai Dallmeier
Vrije Universiteit Brussel,
represented by
Karine Breckpot
BioMARIC,
represented by
Hugo Van Heuverswyn
Zoetis,
represented by
Dieter Vancraeynest
PhaRA,
represented by
Ingrid Theeuwes
Idevax,
represented by
Vanessa Vankerckhoven
What Our Partners Say
The success stories of our partners highlight the transformative impact of collaborating with Immunity for Health. From faster R&D advancements to expanded networks and access to new funding opportunities, our members benefit from tailored support and exclusive resources. Learn how leaders in vaccines, immunotherapy, and infectious disease research are achieving impact through our memberships and strategic partnerships.
